3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
672
Carcinoma, Non-Small-Cell Lung
461
Prostatic Neoplasms
391
Neoplasms
383
Lung Neoplasms
265
Multiple Myeloma
249
Colorectal Neoplasms
235
Neoplasm Metastasis
216
Melanoma
203
Ovarian Neoplasms
166
Leukemia, Myeloid, Acute
165
Pancreatic Neoplasms
156
Carcinoma, Renal Cell
142
Squamous Cell Carcinoma of Head and Neck
141
Lymphoma
137
Brain Neoplasms
133
Leukemia, Lymphocytic, Chronic, B-Cell
126
Glioblastoma
126
Recurrence
125
Lymphoma, Non-Hodgkin
124
Carcinoma, Hepatocellular
119
Head and Neck Neoplasms
114
Urinary Bladder Neoplasms
111
Triple Negative Breast Neoplasms
110
Stomach Neoplasms
109
Precursor Cell Lymphoblastic Leukemia-Lymphoma
105
Uterine Cervical Neoplasms
102
Hematologic Neoplasms
99
Lymphoma, Follicular
96
Sarcoma
95
Interventions
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Unresectable Biliary Tract Cancer
×
1 year
×
Clear all
NCT02632305
2025-06-26
AX-CSARC
AHS Cancer Control Alberta
Phase 2
Active not recruiting
45 enrolled